Tier 2: Partial Documentation Acceptable with Caution Criteria partially met: HPLC purity shown but no MS confirmation, in-house lab only, or COA not batch-specific
Content that may indicate specific health claims for ingredients or delivery systems has not been evaluated by the FDA
Instead, it is designed solely to activate the innate repair receptor (IRR) , the bodys primary switch for tissue protection and anti-inflammation.According to research published in Molecular Pain , ARA-290 is disease-modifying. It works by quieting microglia , the immune cells in the nervous system that drive chronic pain when overactive
Peptide Therapy: Peptide therapy is being researched for its potential to improve wound healing, boost immunity, and increase muscle mass
Pharmacopsychiatry, 55(4): 220227 Novikov M V, Snytnikova O A, Fedunov R G, Yanshole V V, Grivin V P, Plyusnin V F, Xu J, Pozdnyakov I P (2023)